Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dacarbazine-induced photosensitivity reaction

C W Yung, E M Winston, A L Lorincz

    Journal of the American Academy of Dermatology
    |May 1, 1981
    PubMed
    Summary

    Dacarbazine, a chemotherapy for melanoma, can cause immediate photosensitivity skin reactions. Patients receiving dacarbazine should avoid sun exposure after treatment to prevent these adverse effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Comparing Eyesi Virtual Reality Simulator and Traditional Teaching Methods for Direct Ophthalmoscopy: Students' Perspectives at Indiana University School of Medicine.

    Journal of academic ophthalmology (2017)·2023
    Same author

    Studies on the parenteral administration of hydrogen peroxide.

    Federation proceedings·2010
    Same author

    Ocular penetration of levofloxacin, ofloxacin and ciprofloxacin in eyes with functioning filtering blebs: investigator masked, randomised clinical trial.

    The British journal of ophthalmology·2008
    Same author

    Transglutaminase crosslinked gelatin as a tissue engineering scaffold.

    Journal of biomedical materials research. Part A·2007
    Same author

    The response of retrobulbar vasculature to hypercapnia in primary open-angle glaucoma and ocular hypertension.

    Ophthalmic research·2007
    Same author

    Macular pigment optical density before and after cataract extraction.

    Investigative ophthalmology & visual science·2001

    Area of Science:

    • Oncology
    • Dermatology
    • Pharmacology

    Background:

    • Dacarbazine (DTIC-Dome) is a standard chemotherapeutic agent for malignant melanoma.
    • Understanding drug-induced side effects is crucial for patient safety and treatment adherence.

    Observation:

    • Two patients experienced photosensitivity skin reactions shortly after dacarbazine administration.
    • These reactions manifested as immediate adverse cutaneous events.

    Findings:

    • Dacarbazine administration is associated with a risk of developing photosensitivity.
    • The onset of these skin reactions appears to be rapid post-infusion.

    Implications:

    • Healthcare providers should counsel patients on the risk of photosensitivity when prescribing dacarbazine.
    • Patients should be advised to minimize solar exposure following dacarbazine treatment to mitigate this side effect.

    Related Experiment Videos